209
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Novel neuronal and endocrine autoantibody targets in autoimmune polyendocrine syndrome type 1

, , , , , , & show all
Pages 485-494 | Received 02 Nov 2011, Accepted 20 Mar 2012, Published online: 18 May 2012

References

  • Finnish-German APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet. 1997; 17 4: 399–403.
  • Nagamine K, Peterson P, Scott HS, . Positional cloning of the APECED gene. Nat Genet. 1997; 17 4: 393–398.
  • Anderson MS. Autoimmune endocrine disease. Curr Opin Immunol. 2002; 14 6: 760–764.
  • Mathis D, Benoist C. A decade of AIRE. Nat Rev Immunol. 2007; 7 8: 645–650.
  • Betterle C, Greggio NA, Volpato M. Clinical review: autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab. 1998; 83:1049–1055.
  • Clemente MG, Obermayer-Straub P, . Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab. 1997; 82 5: 1353–1361.
  • Perheentupa J. APS-I/APECED: the clinical disease and therapy. Endocrinol Metab Clin North Am. 2002; 31 2: 295–320.
  • Alimohammadi M, Bjorklund P, Hallgren A, . Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. New Engl J Med. 2008; 358:1018–1028.
  • Ekwall O, Hedstrand H, Grimelius L, . Identification of tryptophan hydroxylase as an intestinal autoantigen. Lancet. 1998; 352:279–283.
  • Ahonen P, Myllarniemi S, Sipila I, . Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med. 1990; 322:1829–1836.
  • Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab. 2006; 91 8: 2843–2850.
  • Ward L, Paquette J, Seidman E, Huot C, . Severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: response to immunosuppressive therapy. J Clin Endocrinol Metab. 1999; 84:844–852.
  • Cocco C, Meloni A, Boi F, Pinna G, . Median eminence dopaminergic nerve terminals: A novel target in autoimmune polyendocrine syndrome?. J Clin Endocrinol Metab. 2005; 90 7: 4108–4111.
  • Scherbaum WA, Bottazzo GF. Autoantibodies to vasopressin cells in idiopathic diabetes insipidus: evidence for an autoimmune variant. Lancet. 1983; 1:897–901.
  • Clifton-Bligh P, Lee C, Smith H, . The association of diabetes insipidus with hypoparathyroidism. Addison's disease and mucocutaneous candidiasis. Aust N Z J Med. 1980; 10 5: 548–551.
  • Arvanitakis C, Knouss RF. Selective hypopituitarism. Impaired cell-mediated immunity and chronic mucocutaneous candidiasis. JAMA. 1973; 17:1492–1495.
  • Bensing S, Fetissov SO, Mulder J, . Pituitary autoantibodies in autoimmune polyendocrine syndrome type 1. Proc Natl Acad Sci. 2007; 104 3: 949–954.
  • O'Dwyer DT, Smith AI, Matthew ML, . Identification of the 49-kDa autoantigen associated with lymphocytic hypophysitis as -enolase. J Clin Endocrinol Metab. 2002; 87:752–757.
  • Smith CJA, Oscarson M, Ronnblom L, . TSGA10 – A target for autoantibodies in Autoimmune Polyendocrine Syndrome Type 1 and Systemic Lupus Erythematosus. Scand J Immunol. 2011; 73 2: 147–153.
  • Perniola R, Falorni A, Clemente MG, . Organ-specific and non-organ-specific autoantibodies in children and young adults with autoimmune poly-endocrinopathy-candidiasis-ectodermal dystrophy (APECED). Eur J Endocrinol. 2000; 143:497–503.
  • Soderbergh A, Myhre AG, Ekwall O, . Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab. 2004; 89:557–562.
  • Husebye ES, Gebre-Medhin G, Tuomi T, . Autoantibodies against aromatic L-amino acid decarboxylase in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab. 1997; 82 1: 147–150.
  • Husebye ES, Boe AS, Rorsman F, . Inhibition of aromatic L-amino acid decarboxylase activity by human autoantibodies. Clin Exp Immunol. 2000; 120 3: 420–423.
  • Fetissov SO, Bensing S, Mulder J, . Autoantibodies in autoimmune polyglandular syndrome type I patients react with major brain neurotransmitter systems. J Comp Neurol. 2009; 513 1: 1–20.
  • Scott HS, Heino M, Peterson P, . Common mutations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients of different origins. Mol Endocrinol. 1998; 12 8: 1112–1119.
  • Rosatelli MC, Meloni A, Devoto M, . A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. Hum Genet. 1998; 103 4: 428–434.
  • Ewing DJ, Martyn CN, Young RJ, . The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care. 1989; 8:491–498.
  • Istenes I, Keresztes K, Hermanyi Z, . Relationship between autonomic neuropathy and hypertension–are we underestimating the problem?. Diabet Med. 2008; 25:863–866.
  • Boscolo S, Passoni M, Baldas V, . Detection of anti-brain serum antibodies using a semi-quantitative immunohistological method. J Immunol Meth. 2006; 20 309: 139–149.
  • Yamamoto M, Iguchi G, Takeno R, . Adult combined GH, prolactin, and TSH deficiency associated with circulating PIT-1 antibody in humans. J Clin Invest. 2011; 121 1: 113–119.
  • Manto MU, Laute MA, Aguera M, . Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases. Ann Neurol. 2007; 61 6: 544–551.
  • Valenzise M, Meloni A, Betterle C, . Chronic inflammatory demyelinating polyneuropathy as a possible novel component of autoimmune poly-endocrine-candidiasis-ectodermal dystrophy. Euro J Pediat. 2009; 168:237–240.
  • Björk E, Velloso LA, Kämpe O, Karlsson FA. GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes. Diabetes. 1994; 43 1: 161–165.
  • Tuomi T, Björses P, Falorni A, . Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab. 1996; 81 4: 1488–1494.
  • Brown FM, Kamalesh M, Adri MN, . Anti-adrenal medullary antibodies in IDDM subjects and subjects at high risk of developing IDDM. Diabetes Care. 1988; 11:30–33.
  • Zanone MM, Peakman M, Purewal T, . Autoantibodies to nervous tissue structures are associated with autonomic neuropathy in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1993; 36:564–569.
  • Zanone MM, Favaro E, Catalfamo E, . Autonomic function and autoantibodies to autonomic nervous tissues at follow-up in a cohort of young patients with type 1 diabetes. Effects of serum from diabetic patients on human adrenergic cells. J Neuroimmunol. 2003; 139:66–75.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.